Search
for
Sort by
Research 91–120 of 1000+
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- Penetration of drugs through skin, a complex rate-controlling membrane
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Endocrinology of Transgender Medicine
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Estrogens and the skin
- Targeting the Wnt pathways for therapies
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- The Cytology and Cytochemistry of the Wool Follicle
- FOXO1, TGF-β Regulation and Wound Healing
- The blastema and epimorphic regeneration in mammals
- Production of mannosylerythritol lipids and their application in cosmetics
- Minoxidil versus Nitroglycerin: A Prospective Double-Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- DRUG‐ASSOCIATED ALOPECIA
- Anagen effluvium
- Menopause and aging, quality of life and sexuality
- An Overview of Alopecias
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- 3D printed microneedles: revamping transdermal drug delivery systems
- Skin aging as a mechanical phenomenon: The main weak links
- Update on the dermatologic use of systemic glucocorticosteroids
- Dermal and Transdermal Drug Delivery through Vesicles and Particles: Preparation and Applications
- Gender-Affirming Hormone Therapy for Transgender Females
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?